Today’s PR was good, but it doesn’t much impac
Post# of 154400
(Total Views: 306)
Posted On: 05/06/2019 10:07:27 PM
Today’s PR was good, but it doesn’t much impact the near future. Maybe the 2nd part of the BLA will finally be submitted because they finally figured out that the 525mg is the way to go? Hopefully.
What we need is the TNBC trial to happen and a deal on the prostate test to close. Or maybe even a deal for combo and/or mono therapy. CYDY needs cash.
Hanging around this .40 is worrisome because if CYDY raises funds at this range, we’re going to tank to .30. I understand the long term play, I’ve been here since 2015, but at some point we as investors have to say mercy.
I have faith the NP will pulp through, and the RPs cancer knowledge will make Leronlimab a household name for cancer, but at what cost to us.
What we need is the TNBC trial to happen and a deal on the prostate test to close. Or maybe even a deal for combo and/or mono therapy. CYDY needs cash.
Hanging around this .40 is worrisome because if CYDY raises funds at this range, we’re going to tank to .30. I understand the long term play, I’ve been here since 2015, but at some point we as investors have to say mercy.
I have faith the NP will pulp through, and the RPs cancer knowledge will make Leronlimab a household name for cancer, but at what cost to us.
(0)
(0)